-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 RutvWxX0AoL62mdb7g1jYidTmZPAX3wmDXSiblNPRmtD4QiUdKETbVwAr/8zmcSJ
 UJCG8rIRRV3tP7FSatI1bA==

<SEC-DOCUMENT>0000950116-01-000287.txt : 20010224
<SEC-HEADER>0000950116-01-000287.hdr.sgml : 20010224
ACCESSION NUMBER:		0000950116-01-000287
CONFORMED SUBMISSION TYPE:	SC 13D
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20010221
GROUP MEMBERS:		CAN-MED TECHNOLOGY, INC D/B/A GREEN DIAMOND CORP.
GROUP MEMBERS:		DEZWIREK PHILLIP
GROUP MEMBERS:		ICARUS INVESTMENT CORPORATION
GROUP MEMBERS:		JASON LOUIS DEZWIREK
GROUP MEMBERS:		PHILLIP DEZWIREK

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CECO ENVIRONMENTAL CORP
		CENTRAL INDEX KEY:			0000003197
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL & COMMERCIAL FANS & BLOWERS & AIR PURIFYING EQUIP [3564]
		IRS NUMBER:				132566064
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D
		SEC ACT:		
		SEC FILE NUMBER:	005-19763
		FILM NUMBER:		1550984

	BUSINESS ADDRESS:	
		STREET 1:		505 UNIVERSITY AVE
		STREET 2:		STE 1400
		CITY:			TORONTO ONTARIO MSG
		STATE:			A6
		BUSINESS PHONE:		4165936543

	MAIL ADDRESS:	
		STREET 1:		111 ELIZABETH STREET SUITE 600
		CITY:			TORONTO ONTARIO
		STATE:			A6

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	API ENTERPRISES INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ALARM PRODUCTS INTERNATIONAL INC
		DATE OF NAME CHANGE:	19851210

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DEZWIREK PHILLIP
		CENTRAL INDEX KEY:			0000897715
		STANDARD INDUSTRIAL CLASSIFICATION:	 []

	FILING VALUES:
		FORM TYPE:		SC 13D

	BUSINESS ADDRESS:	
		STREET 1:		111 ELIZABETH STREET
		STREET 2:		SUITE 600
		CITY:			TORONTO
		STATE:			A6
		BUSINESS PHONE:		3127049400

	MAIL ADDRESS:	
		STREET 1:		111 ELIZABETH STREET
		STREET 2:		SUITE 600
		CITY:			TORONTO ONTARIO
		STATE:			A6
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D
<SEQUENCE>1
<FILENAME>0001.txt
<DESCRIPTION>SCHEDULE 13D
<TEXT>

<PAGE>

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  SCHEDULE 13D

                    UNDER THE SECURITIES EXCHANGE ACT OF 1934
                               (AMENDMENT NO. 9)*

                            CECO Environmental Corp.
 ------------------------------------------------------------------------------
                                (Name of Issuer)

                                  Common Stock
 ------------------------------------------------------------------------------
                         (Title of Class of Securities)

                                   001-858-109
                    ----------------------------------------
                                 (CUSIP Number)
                                Phillip DeZwirek
                        505 University Avenue, Suite 1400
                         Toronto, Ontario CANADA M5G 1X3
 ------------------------------------------------------------------------------
   (Name, Address and Telephone Number of Person Authorized to Receive Notices
                               and Communications)

                      January 2, 2001 and February 14, 2001
          ------------------------------------------------------------
             (Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report
the acquisitions which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box / /.

Check the following box if a fee is being paid with the statement / /. (A fee is
not required only if the reporting person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)

NOTE: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are to be
sent.

*The Remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the act (however, see the
Notes).
<PAGE>


                                  SCHEDULE 13D
CUSIP NO. 001-858-109                                              Page 2 of 9
          -----------

==============================================================================
1        NAME OF REPORTING PERSON
         S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

                  Icarus Investment Corp.
- ------------------------------------------------------------------------------
2        CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP             (a)  / /
                                                                      (b)  / /

- ------------------------------------------------------------------------------
3        SEC USE ONLY

- ------------------------------------------------------------------------------
4        SOURCE OF FUNDS*

                  OO (no change of ownership is reported)
- ------------------------------------------------------------------------------
5        CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED           / /
         PURSUANT TO ITEMS 2(d) OR 2(E)

- ------------------------------------------------------------------------------
6        CITIZENSHIP OR PLACE OR ORGANIZATION

         Delaware
- ------------------------------------------------------------------------------
 NUMBER OF                           7        SOLE VOTING POWER
  SHARES
BENEFICIALLY                                1,334,360
 OWNED BY                           ------------------------------------------
   EACH                              8        SHARED VOTING POWER
 REPORTING
PERSON WITH                                   800,000
                                    ------------------------------------------
                                     9       SOLE DISPOSITIVE POWER

                                            1,334,360
                                    ------------------------------------------
                                    10       SHARED DISPOSITIVE POWER

                                              800,000
- ------------------------------------------------------------------------------
11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

                    2,134,360
- ------------------------------------------------------------------------------
12  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)                          / /
    EXCLUDES CERTAIN SHARES
- ------------------------------------------------------------------------------
13  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

                  24.15%
- ------------------------------------------------------------------------------
14  TYPE OF REPORTING PERSON

                  CO
- ------------------------------------------------------------------------------
                      *SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>


                                  SCHEDULE 13D
CUSIP NO. 001-858-109                                              Page 3 of 9
          -----------

==============================================================================
1        NAME OF REPORTING PERSON
         S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

                  Phillip DeZwirek
- ------------------------------------------------------------------------------
2        CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP             (a)  / /
                                                                      (b)  / /

- ------------------------------------------------------------------------------
3        SEC USE ONLY

- ------------------------------------------------------------------------------
4        SOURCE OF FUNDS*

                  OO (no change of ownership is reported)
- ------------------------------------------------------------------------------
5        CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED           / /
         PURSUANT TO ITEMS 2(d) OR 2(E)

- ------------------------------------------------------------------------------
6        CITIZENSHIP OR PLACE OR ORGANIZATION

                  Canadian citizen

- ------------------------------------------------------------------------------
 NUMBER OF                           7       SOLE VOTING POWER
  SHARES
BENEFICIALLY                                2,374,197
 OWNED BY                           ------------------------------------------
   EACH                              8       SHARED VOTING POWER
 REPORTING
PERSON WITH                                 2,134,360
                                    ------------------------------------------
                                     9       SOLE DISPOSITIVE POWER

                                            2,374,197
                                    ------------------------------------------
                                    10       SHARED DISPOSITIVE POWER

                                            2,134,360
- ------------------------------------------------------------------------------
11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

                    4,508,557
- ------------------------------------------------------------------------------
12  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)                          / /
    EXCLUDES CERTAIN SHARES


- ------------------------------------------------------------------------------
13  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

                  40.66%
- ------------------------------------------------------------------------------
14       TYPE OF REPORTING PERSON

                  IN
<PAGE>


                                  SCHEDULE 13D
CUSIP NO. 001-858-109                                              Page 4 of 9
          -----------

==============================================================================
1        NAME OF REPORTING PERSON
         S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

                  Jason Louis DeZwirek
- ------------------------------------------------------------------------------
2        CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP             (a)  / /
                                                                      (b)  / /

- ------------------------------------------------------------------------------
3        SEC USE ONLY

- ------------------------------------------------------------------------------
4        SOURCE OF FUNDS*

                  OO (no change of ownership is reported)
- ------------------------------------------------------------------------------
5        CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED           / /
         PURSUANT TO ITEMS 2(d) OR 2(E)


- ------------------------------------------------------------------------------
6        CITIZENSHIP OR PLACE OR ORGANIZATION

                  Canadian citizen
- ------------------------------------------------------------------------------
  NUMBER OF                          7        SOLE
VOTING POWER
  SHARES
BENEFICIALLY                                1,598,666
 OWNED BY                           ------------------------------------------
   EACH                              8        SHARED VOTING POWER
 REPORTING
PERSON WITH                                 2,134,360
                                    ------------------------------------------
                                     9        SOLE DISPOSITIVE POWER

                                            1,598,666
                                    ------------------------------------------
                                    10        SHARED DISPOSITIVE POWER

                                            2,134,360
- ------------------------------------------------------------------------------
11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

                    3,733,026
- ------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)                           / /
   EXCLUDES CERTAIN SHARES


- ------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

                  42.24%
- ------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON

                  IN
<PAGE>

                                  SCHEDULE 13D
CUSIP NO. 001-858-109                                              Page 5 of 9
          -----------

==============================================================================
1        NAME OF REPORTING PERSON
         S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

                  Can-Med Technology, Inc. d/b/a Green Diamond Corp.
- ------------------------------------------------------------------------------
2        CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP             (a)  / /
                                                                      (b)  / /

- ------------------------------------------------------------------------------
3        SEC USE ONLY

- ------------------------------------------------------------------------------
4        SOURCE OF FUNDS*

                  WC
- ------------------------------------------------------------------------------
5        CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED           / /
         PURSUANT TO ITEMS 2(d) OR 2(E)

- ------------------------------------------------------------------------------
6        CITIZENSHIP OR PLACE OR ORGANIZATION

         Ontario

- ------------------------------------------------------------------------------
 NUMBER OF                           7   SOLE VOTING POWER
  SHARES
BENEFICIALLY                                800,000
 OWNED BY                           ------------------------------------------
   EACH                              8   SHARED VOTING POWER
 REPORTING
PERSON WITH
                                    ------------------------------------------
                                     9   SOLE DISPOSITIVE POWER

                                            800,000
                                    ------------------------------------------
                                    10   SHARED DISPOSITIVE POWER

- ------------------------------------------------------------------------------
11       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

                    800,000
- ------------------------------------------------------------------------------
12       CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)                     / /
         EXCLUDES CERTAIN SHARES


- ------------------------------------------------------------------------------
13       PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

                  9.05%
- ------------------------------------------------------------------------------
14       TYPE OF REPORTING PERSON

                  CO
- ------------------------------------------------------------------------------
                      *SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>


                                  SCHEDULE 13D
CUSIP NO. 001-858-109                                             Page 6 of 9
          -----------

         Amendment No. 9 to Schedule 13D filed by Icarus Investment Corp.
("Icarus"), Phillip DeZwirek, Jason Louis DeZwirek and Can-Med Technology, Inc.
("Can-Med") relating to the issuance of warrants to purchase 500,000 shares of
common stock of CECO Environmental Corp. ("CECO") to Phillip DeZwirek and the
purchase by Mr. DeZwirek of a total of 118,700 shares of common stock of CECO.

Items 3-7 inclusive for Phillip DeZwirek.

Item 3.  Source and Amount of Funds or Other Considerations.

         On August 14, 2000, warrants to purchase 500,000 shares of common stock
of CECO that became exercisable on August 14, 2001, were issued to Mr. DeZwirek
for consideration of $10.00; Mr. DeZwirek paid such amount with personal funds.
Mr. DeZwirek also purchased 118,700 shares of common stock of CECO in the open
market with $172,205 of his own funds.

Item 4.  Purpose of Transaction.

         Mr. DeZwirek acquired the warrants to purchased 500,000 share of common
stock of CECO for investment purposes. Mr. DeZwirek purchased 118,700 shares of
common stock of CECO for investment purposes.

Item 5.  Interest in Securities of the Issuer.

         (a) Phillip DeZwirek is deemed to beneficially own all securities
underlying the 800,000 warrants to purchase shares of common stock of CECO held
by Can-Med, all 1,334,360 shares of common stock of CECO owned directly by
Icarus and the 124,197 shares of CECO that he owns directly and the securities
underlying the warrants he owns directly to purchase 2,250,000 shares of common
stock of CECO, which represents 40.66% of the outstanding common stock of CECO
(including as outstanding the securities underlying the warrants to purchase
2,250,000 shares of common stock of CECO held by Mr. DeZwirek and the securities
underlying the warrants to purchase 800,000 shares of common stock of CECO held
by Can-Med). Of such amount 7.22% is attributable to Mr. DeZwirek's ownership of
shares of common stock of CECO indirectly through Can-Med, 12.03% is
attributable to Mr. DeZwirek's ownership of shares of common stock of CECO
indirectly through Icarus and 21.41% is attributable to Mr. DeZwirek's direct
ownership of shares of and warrants for common stock of CECO.

         (b) Phillip DeZwirek has sole voting and sole dispositive power with
respect to the 124,197 shares of common stock of CECO and the warrants to
purchase 2,250,000 shares of common stock of CECO that he owns directly. As a
result of Phillip DeZwirek being the Chief Executive Officer and a 50%
shareholder of Icarus, and Icarus' 50.1% ownership of Can-Med, Mr. DeZwirek
controls Icarus and Can-Med. Phillip DeZwirek has shared voting power and shared
dispositive power with respect to the 1,334,360 shares of common stock of CECO
owned by Icarus and the securities underlying the warrants to purchase 800,000
shares of common stock of CECO owned by Can-Med. Such power is shared with Jason
DeZwirek, Icarus and Can-Med.

         (c) During the past 60 days, Phillip DeZwirek has entered into the
following transactions in CECO's common stock:

Type of Transaction:    Number of Shares:   Price Per Share:   Date:
- -------------------     ----------------    ---------------    ----
Open Market Purchase    15,000              $1.39              January 2, 2001
Open Market Purchase    78,200              $1.40              January 2, 2001
Open Market Purchase    500                 $1.43              January 3, 2001
Open Market Purchase    7,000               $1.50              January 4, 2001
Open Market Purchase    8,000               $1.68              January 8, 2001
Open Market Purchase    10,000              $1.75              January 10, 2001

         (d) Phillip DeZwirek is the only person known to have the right to
receive or the power to direct the receipt of dividends from, or the proceeds of
the 2,374,197 shares of the common stock of CECO, including the common stock
<PAGE>

                                  SCHEDULE 13D
CUSIP NO. 001-858-109                                               Page 7 of 9
          -----------

underlying the 2,250,000 warrants to purchase common stock of CECO, owned
directly by him. Phillip DeZwirek controls Icarus. Icarus controls Can-Med.
Icarus owns 50.1% of the outstanding stock of Can-Med. Phillip DeZwirek owns 50%
of the outstanding stock of Icarus. Mr. Jason Louis DeZwirek is the only person
other than Phillip DeZwirek and Icarus who is known to have the right to receive
or the power to direct the receipt of dividends from, or the proceeds of the
sale of, the shares of common stock of CECO owned by Icarus and the only person
other than Phillip DeZwirek, Icarus and Can-Med who is known to have the right
to receive or the power to direct the receipt of dividends from, or the proceeds
from the sale of the warrants to purchase 800,000 shares of common stock of CECO
owned by Can-Med. The interests of Can-Med, Icarus, Phillip DeZwirek and Jason
DeZwirek in the common stock of CECO relate to more than 5% interests in the
common stock of CECO.

         (e) Not applicable.

Item 6.  Contracts, Arrangements, Understandings or Relationships with Respect
         to Securities of the Issuer.

         None

Item 7.  Material to be Filed as Exhibits.

         A joint filing statement is filed as an exhibit to this Amendment No. 9
to Schedule 13D.
<PAGE>



                                   Signatures

         After reasonable inquiry and to the best of our knowledge and belief,
the undersigned certify that the information set forth in this statement is
true, complete and correct.

Dated: February 21, 2000                       ICARUS INVESTMENT CORP.


                                               By: /s/ Phillip DeZwirek
                                                  ----------------------------
                                                  Phillip DeZwirek
                                                  Chief Executive Officer


                                               /s/ Phillip DeZwirek
                                               -------------------------------
                                               Phillip DeZwirek


                                               /s/ Jason Louis DeZwirek
                                               -------------------------------
                                               Jason Louis DeZwirek

                                               CAN-MED TECHNOLOGY, INC.


                                               By: /s/ Phillip DeZwirek
                                                  ----------------------------
                                                   Phillip DeZwirek
                                                   President
<PAGE>

                   EXHIBIT TO AMENDMENT NO. 9 TO SCHEDULE 13D
                             DATED February 21, 2001
                                       OF
                             ICARUS INVESTMENT CORP.
                                PHILLIP DEZWIREK
                              JASON LOUIS DEZWIREK
                          AND CAN-MED TECHNOLOGY, INC.

                             JOINT FILING AGREEMENT


         Icarus Investment Corp. ("Icarus"), Phillip DeZwirek ("DeZwirek"),
Jason Louis DeZwirek ("JLD") and Can-Med Technology, Inc. ("Can-Med") hereby
agree that the Amendment No. 9 to Schedule 13D to which this statement is
attached is filed on behalf of Icarus, DeZwirek, JLD and Can-Med and that any
amendments to this Schedule 13D may be filed on behalf of Icarus, DeZwirek, JLD
and Can-Med.



                                           ICARUS INVESTMENT CORP.


                                           By: /s/ Phillip DeZwirek
                                              ----------------------------
                                              Phillip DeZwirek
                                              Chief Executive Officer


                                           /s/ Phillip DeZwirek
                                           -------------------------------
                                           Phillip DeZwirek


                                           /s/ Jason Louis DeZwirek
                                           -------------------------------
                                           Jason Louis DeZwirek

                                           CAN-MED TECHNOLOGY, INC.


                                           By: /s/ Phillip DeZwirek
                                              ----------------------------
                                              Phillip DeZwirek
                                              President
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
